Per Bümming

Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era

Bengt Nilsson, Per Bümming, Jeanne M. Meis‐Kindblom et al. · Cancer · 2005 · 1.3K citations · Full text

Medicine, Oncology, Surgery +13

Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor Prognosis

Johanna C. Andersson‐Assarsson, Per Bümming, Jeanne M. Meis‐Kindblom et al. · Gastroenterology · 2006 · 239 citations · Full text

Medicine, Oncology, Pathology +12

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients

Per Bümming, Jeanne M. Meis‐Kindblom, Hans Klingenstierna et al. · British Journal of Cancer · 2003 · 143 citations · Full text

Medicine, Oncology, Pharmacology +16

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)

Bengt‐Olof Nilsson, K. Sjölund, Kindblom Lg et al. · British Journal of Cancer · 2007 · 133 citations · Full text

Medicine, Oncology, Surgery +12

Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours

Per Bümming, H. Ahlman, Jeanne M. Meis‐Kindblom et al. · British journal of surgery · 2006 · 67 citations · Full text

Medicine, Oncology, Surgery +14